HLA-G∗01:04∼UTR3 Recipient Correlates with Lower Survival and Higher Frequency of Chronic Rejection after Lung Transplantation

American Journal of Transplantation

Volumn 15, Issue 9, 2015, Pages 2413-2420

  Di Cristofaro, J ^a   Reynaud Gaubert, M ^b   Carlini, F ^a   Roubertoux, P ^b   Loundou, A ^c   Basire, A ^d   Frassati, C ^d   Thomas, P ^e   Gomez, C ^b   Picard, C ^a,d  

^a AIX MARSEILLE UNIVERSITÉ   (France)

^b AIX MARSEILLE UNIVERSITY   (France)

^c ASSISTANCE PUBLIQUE HÔPITAUX DE MARSEILLE   (France)

^d ETABLISSEMENT FRANÇAIS DU SANG   (France)

^e HÔPITAL NORD   (France)

Author keywords

Bronchiolitis obliterans (BOS); function dysfunction; genetics; immune regulation; lung (allograft); rejection: antibody mediated (ABMR)

Indexed keywords

HLA ANTIBODY; HLA G ANTIGEN; 3' UNTRANSLATED REGION;

2' UNTRANSLATED REGION; 3' UNTRANSLATED REGION; ADULT; ALLELE; ALLOIMMUNIZATION; ARTICLE; CHRONIC GRAFT REJECTION; CONTROLLED STUDY; CYSTIC FIBROSIS; FEMALE; GENE FREQUENCY; GRAFT RECIPIENT; GRAFT SURVIVAL; HAPLOTYPE; HUMAN; LONG TERM SURVIVAL; LUNG TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; UNTRANSLATED REGION; ADVERSE EFFECTS; CHRONIC DISEASE; CLINICAL TRIAL; FOLLOW UP; GENETICS; GRAFT REJECTION; LUNG DISEASES; MORTALITY; PHYSIOLOGY; POSTOPERATIVE COMPLICATION; PROGNOSIS; RETROSPECTIVE STUDY; RISK FACTOR; SURVIVAL RATE;

3' UNTRANSLATED REGIONS; ADULT; CHRONIC DISEASE; FEMALE; FOLLOW-UP STUDIES; GRAFT REJECTION; GRAFT SURVIVAL; HAPLOTYPES; HLA-G ANTIGENS; HUMANS; LUNG DISEASES; LUNG TRANSPLANTATION; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE; POSTOPERATIVE COMPLICATIONS; PROGNOSIS; RETROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL RATE;

EID: 84939573140     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/ajt.13305     Document Type: Article

References (35)

1. Zamora MR,. Updates in lung transplantation. Clin Transpl 2012; 26: 185-192.
2. Jaramillo A, Fernandez FG, Kuo EY, Trulock EP, Patterson GA, Mohanakumar T,. Immune mechanisms in the pathogenesis of bronchiolitis obliterans syndrome after lung transplantation. Pediatr Transplant 2005; 9: 84-93.
3. Martinu T, Chen DF, Palmer SM,. Acute rejection and humoral sensitization in lung transplant recipients. Proc Am Thorac Soc 2009; 6: 54-65.
4. Ho EK, Vlad G, Colovai AI, et al., Alloantibodies in heart transplantation. Hum Immunol 2009; 70: 825-829.
5. Lee PC, Zhu L, Terasaki PI, Everly MJ,. HLA-specific antibodies developed in the first year posttransplant are predictive of chronic rejection and renal graft loss. Transplantation 2009; 88: 568-574.
6. Safavi S, Robinson DR, Soresi S, Carby M, Smith JD,. De novo donor HLA-specific antibodies predict development of bronchiolitis obliterans syndrome after lung transplantation. J Heart Lung Transplant 2014; 33: 1273-1281.
7. Rebmann V, da Silva Nardi F, Wagner B, Horn PA,. HLA-G as a Tolerogenic Molecule in Transplantation and Pregnancy. J Immunol Res 2014; 2014: 297073.
8. Brugiere O, Thabut G, Pretolani M, et al., Immunohistochemical study of HLA-G expression in lung transplant recipients. Am J Transplant 2009; 9: 1427-1438.
9. White SR, Floreth T, Liao C, Bhorade SM,. Association of soluble HLA-G with acute rejection episodes and early development of bronchiolitis obliterans in lung transplantation. PLoS ONE 2014; 9: e103643.
10. Lynge Nilsson L, Djurisic S, Hviid TV,. Controlling the immunological crosstalk during conception and pregnancy: HLA-G in reproduction. Front Immunol 2014; 5: 198.
11. Rouas-Freiss N, Goncalves RM, Menier C, Dausset J, Carosella ED,. Direct evidence to support the role of HLA-G in protecting the fetus from maternal uterine natural killer cytolysis. Proc Natl Acad Sci USA 1997; 94: 11520-11525.
12. Yan WH, Fan LA,. Residues Met76 and Gln79 in HLA-G alpha1 domain involve in KIR2DL4 recognition. Cell Res 2005; 15: 176-182.
13. Allan DS, Lepin EJ, Braud VM, O'Callaghan CA, McMichael AJ,. Tetrameric complexes of HLA-E, HLA-F, and HLA-G. J Immunol Methods 2002; 268: 43-50.
14. Howangyin KY, Loustau M, Wu J, et al., Multimeric structures of HLA-G isoforms function through differential binding to LILRB receptors. Life Sci 2012; 69: 4041-4049.
15. Carlini F, Traore K, Cherouat N, et al., HLA-G UTR haplotype conservation in the Malian population: Association with soluble HLA-G. PLoS ONE 2013; 8: e82517.
16. Di Cristofaro J, El Moujally D, Agnel A, et al., HLA-G haplotype structure shows good conservation between different populations and good correlation with high, normal and low soluble HLA-G expression. Hum Immunol 2013; 74: 203-206.
17. Ciliao Alves DC, de Oliveira Crispim JC, Castelli EC, et al., Human leukocyte antigen-G 3' untranslated region polymorphisms are associated with better kidney allograft acceptance. Hum Immunol 2012; 73: 52-59.
18. Twito T, Joseph J, Mociornita A, Rao V, Ross H, Delgado DH,. The 14-bp deletion in the HLA-G gene indicates a low risk for acute cellular rejection in heart transplant recipients. J Heart Lung Transplant 2011; 30: 778-782.
19. Torres MI, Luque J, Lorite P, et al., 14-Base pair polymorphism of human leukocyte antigen-G as genetic determinant in heart transplantation and cyclosporine therapy monitoring. Hum Immunol 2009; 70: 830-835.
20. Crispim JC, Mendes-Junior CT, Wastowski IJ, et al., Frequency of insertion/deletion polymorphism in exon 8 of HLA-G and kidney allograft outcome. Tissue Antigens 2008; 71: 35-41.
21. Misra MK, Prakash S, Kapoor R, Pandey SK, Sharma RK, Agrawal S,. Association of HLA-G promoter and 14-bp insertion-deletion variants with acute allograft rejection and end-stage renal disease. Tissue Antigens 2013; 82: 317-326.
22. Yousem SA, Berry GJ, Cagle PT, et al., Revision of the 1990 working formulation for the classification of pulmonary allograft rejection: Lung Rejection Study Group. J Heart Lung Transplant 1996; 1: 1-15.
23. Stewart S, Fishbein MC, Snell GI, et al., Revision of the 1996 working formulation for the standardization of nomenclature in the diagnosis of lung rejection. J Heart Lung Transplant 2007; 26: 1229-1242.
24. Estenne M, Maurer JR, Boehler A, et al., Bronchiolitis obliterans syndrome 2001: An update of the diagnostic criteria. J Heart Lung Transplant 2002; 21: 297-310.
25. Di Cristofaro J, Buhler S, Frassati C, et al., Linkage disequilibrium between HLA-G∗0104 and HLA-E∗0103 alleles in Tswa Pygmies. Tissue Antigens 2011; 77: 193-200.
26. Deschaseaux F, Gaillard J, Langonne A, et al., Regulation and function of immunosuppressive molecule human leukocyte antigen G5 in human bone tissue. Faseb J 2013; 27: 2977-2987.
27. Clements CS, Kjer-Nielsen L, Kostenko L, et al., Crystal structure of HLA-G: A nonclassical MHC class I molecule expressed at the fetal-maternal interface. Proc Natl Acad Sci USA 2005; 102: 3360-3365.
28. Sheshgiri R, Rouas-Freiss N, Rao V, et al., Myocardial HLA-G reliably indicates a low risk of acute cellular rejection in heart transplant recipients. J Heart Lung Transplant 2008; 27: 522-527.
29. Zarkhin V, Talisetti A, Li L, et al., Expression of soluble HLA-G identifies favorable outcomes in liver transplant recipients. Transplantation 2010; 90: 1000-1005.
30. Pabon MA, Navarro CE, Osorio JC, et al., Impact of human leukocyte antigen molecules e, f, and g on the outcome of transplantation. Transplant Proc 2014; 46: 2957-2965.
31. Rebmann V, van der Ven K, Passler M, Pfeiffer K, Krebs D, Grosse-Wilde H,. Association of soluble HLA-G plasma levels with HLA-G alleles. Tissue Antigens 2001; 57: 15-21.
32. Naji A, Menier C, Morandi F, et al., Binding of HLA-G to ITIM-bearing Ig-like transcript 2 receptor suppresses B cell responses. J Immunol 2014; 192: 1536-1546.
33. Moreau P, Contu L, Alba F, et al., HLA-G gene polymorphism in human placentas: Possible association of G∗0106 allele with preeclampsia and miscarriage. Biol Reprod 2008; 79: 459-467.
34. Tan CY, Ho JF, Chong YS, et al., Paternal contribution of HLA-G∗0106 significantly increases risk for pre-eclampsia in multigravid pregnancies. Mol Hum Reprod 2008; 14: 317-324.
35. Robinson J, Halliwell JA, McWilliam H, Lopez R, Parham P, Marsh SGE,. The IMGT/HLA database. Nucleic Acids Res 2013; 41 (D1): D1222-D1227.